Article Details
Retrieved on: 2022-07-26 10:49:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Goldman Sachs Group started coverage on shares of Vor Biopharma in a research report on Wednesday, April 27th. They set a neutral rating and a ...
Article found on: www.etfdailynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here